Sudeep Pharma Q2 Results: Revenue rises but profit down, margins narrow

Sudeep Pharma reports Q2 revenue growth but lower profits after Dalal Street debut. Shares of Sudeep Pharma ended higher on Friday, December 19, by 1.46% at ₹684 on the NSE.

Leave a Reply

Your email address will not be published. Required fields are marked *